NDC 83090-005-01 - NA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83090-005
- Requested NDC
- 83090-005-01
- Package NDCs from labels
- 83090-005-01, 83090-005-10
- Manufacturer
- Sintetica US LLC | SINTETICA SA
- Effective date
- 2022-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NA - Sintetica US LLC | SINTETICA SA | Sintetica US LLC | SINTETICA SA | 2022-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 83090-005-10 | 2026-01-29 | C162847 | 48780-1 | 49896155-bf71-586f-e063-e6dba90add90 | LIDOCAINE HYDROCHLORIDE INJECTION, USP 1% LIDOCAINE HYDROCHLORIDE INJECTION, USP 2% For Infiltration and Nerve Block Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83090-005-01 | NA | 5 mL in 1 AMPULE | INJECTION, SOLUTION | 5 | 1 | |
| 83090-005-10 | NA | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83090-005-10 | ML - Milliliter | 83090-005 | 172f059a-6028-4a82-8ee8-c60b408abd5b | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09af094-7cfc-1d47-e053-2a95a90a6b69 | 2024-02-22 | Warnings, Adverse reactions | EC2CNF7XFP |
| GI Drainage | CINNAMOMUM, GENTIANA LUTEA, SYZYGIUM JAMBOLANUM, ARGENTUM NITRICUM, COLCHICUM AUTUMNALE, COLOSTRUM (BOVINE), COPPER GLUCONATE, LAPPA MAJOR, LYCOPODIUM CLAVATUM, MAGNESIUM GLUCONICUM, MANGANESE GLUCONATE, PANCREAS SUIS, POTASSIUM GLUCONATE, RUMEX CRISPUS, STOMACH (SUIS), AURUM METALLICUM, CALCAREA CARBONICA, CARBO VEGETABILIS, INTESTINE (SUIS), MALUS PUMILA, FLOS, NITRICUM ACIDUM, PRUNUS CERASIFERA, FLOS, ROCK WATER, SCHROPHULARIA NODOSA, FAGUS SYLVATICA, FLOS | Deseret Biologicals, Inc. | ff81e3ca-2f88-4daf-a734-083107269d3a | 2024-02-21 | Warnings | 059QF0KO0R |
| Bladder Relief | CAUSTICUM, NATRUM MURIATICUM, NUX VOMICA, PULSATILLA (VULGARIS), SEPIA, STAPHYSAGRIA, THUJA OCCIDENTALIS | The Magni Company | b09bf037-703f-4c22-8535-b33d586ebefa | 2024-02-08 | Warnings | 451W47IQ8X |
| Lidocaine Hemorrhoid | LIDOCAINE HCL, PHENYLEPHRINE HCL, WITCH HAZEL | Walgreens Co | 10a47899-f4a0-66e8-e063-6394a90a11dd | 2024-02-05 | Warnings | EC2CNF7XFP |
| Sterile Water | STERILE WATER | Chartwell RX, LLC | 3681eeaa-807a-47ca-9fbc-61c2b682800a | 2024-02-01 | 059QF0KO0R | |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | 1737761 |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | 1737761 |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | e3b3b462-8f35-68b8-e053-2995a90a6403 | 2024-01-27 | Warnings, Adverse reactions | EC2CNF7XFP |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | 1737761 |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | 1737568 |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| XYLOCAINE- MPF (LIDOCAINE HCl ) | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8b987c8-b5cb-74cd-e053-2a95a90a5a93 | 2024-01-27 | Warnings, Adverse reactions | 1737761 EC2CNF7XFP |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 971439ed-4507-7a30-e053-2a95a90a1f1c | 2024-01-22 | Warnings, Adverse reactions | EC2CNF7XFP |
| LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 94e9f2db-af29-032e-e053-2995a90a7f7b | 2024-01-22 | Warnings, Adverse reactions | EC2CNF7XFP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.